| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/03/2009 | US20090221637 Solid-state salt argatroban formulations and methods for producing and using the same |
| 09/03/2009 | US20090221636 Argatroban formulations and methods for making and using same |
| 09/03/2009 | US20090221635 Quinolinyl and benzothiazolyl modulators |
| 09/03/2009 | US20090221634 Compositions and Methods for Disruption of BRCA2-Rad51 Interaction |
| 09/03/2009 | US20090221633 Inhibitors of akt (protein kinase b) |
| 09/03/2009 | US20090221632 Bicyclo-Pyrazoles and Pharmaceutical Compositions Comprising Them |
| 09/03/2009 | US20090221631 Imidazopyridinones |
| 09/03/2009 | US20090221630 Iap inhibitors |
| 09/03/2009 | US20090221629 Drug screening; antagonizing macrophage migration inhibitory factor (MIF) using ibudilast; neuropathic pain; identifying agents useful for opiate withdrawal and for treating other addictions and dependence |
| 09/03/2009 | US20090221628 Compositions and methods for treatment of prostate and breast cancer |
| 09/03/2009 | US20090221627 Fluoro-containing derivatives of hydrogenated pyrido[4,3-b]indoles with neuroprotective and cognition enhancing properties, process for preparing, and use |
| 09/03/2009 | US20090221626 Aerosol formulation for inhalation containing an anticholinergic agent |
| 09/03/2009 | US20090221625 Cosmeceutical composition |
| 09/03/2009 | US20090221624 4-aminoquinoline compounds for treating virus-related conditions |
| 09/03/2009 | US20090221623 Indole Alkaloid Derivatives Having Opioid Receptor Agonistic Effect, and Therapeutic Compositions and Methods Relating to Same |
| 09/03/2009 | US20090221622 Topotecan ready to use solutions |
| 09/03/2009 | US20090221621 Methods of Reducing Alcohol-Induced Dose Dumping for Opioid Sustained Release Oral Dosage Forms |
| 09/03/2009 | US20090221620 Gentic polymorphisms associated with stroke, methods of detection and uses thereof |
| 09/03/2009 | US20090221618 Azabicyclo (3, 1, 0) hexan derivatives useful as modulators of dopamine d3 receptors |
| 09/03/2009 | US20090221617 Lead compound of anti-hypertensive drug and method for screening the same |
| 09/03/2009 | US20090221616 Quinazoline derivatives as egf and/or erbb2 tyrosine kinase inhibitors |
| 09/03/2009 | US20090221615 Combination anti-cancer agents |
| 09/03/2009 | US20090221614 Selective serine/threonine kinase inhibitors |
| 09/03/2009 | US20090221613 Use of Adenine-Derived Compounds for the Treatment of Lupus |
| 09/03/2009 | US20090221612 Certain substituted amides, method of making, and method of use thereof |
| 09/03/2009 | US20090221611 Fused Triazole Tachykinin Receptor Antagonists |
| 09/03/2009 | US20090221610 Compositions and Methods for Treating Cognitive Disorders |
| 09/03/2009 | US20090221609 Gene Predictors of Response to Metastatic Colorectal Chemotherapy |
| 09/03/2009 | US20090221608 3-({4-[1-(2,2-difluoroethyl)-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazol-4-yl]pyrimidin-2-yl}amino)propanenitrile, used as serine/threonine protein kinase inhibitors, for the treatment of disease states associated with abnormal cell growth such as cancer |
| 09/03/2009 | US20090221607 Piperazine Derivatives |
| 09/03/2009 | US20090221606 Crystalline (3-cyano-1h-indol-7-yl)-[4-(4-fluorophenethyl) piperazin-1-ylimethanone phosphate |
| 09/03/2009 | US20090221605 Substituted pyrrole-2, 5-diones as protein kinase c inhibitors |
| 09/03/2009 | US20090221604 Thiazole Compounds and Their Use as PGD2 Antagonists |
| 09/03/2009 | US20090221603 Heterocyclic amide derivatives as calcium channel blockers |
| 09/03/2009 | US20090221602 Processes for preparing substituted pyrimidines |
| 09/03/2009 | US20090221601 Methods of identifying and treating individuals exhibiting mutant kit protein |
| 09/03/2009 | US20090221600 Pyrido-pyridimidine derivatives useful as antiinflammatory agents |
| 09/03/2009 | US20090221599 Phthalazinone pyrazole derivatives, their manufacture and use as pharmaceutical agents |
| 09/03/2009 | US20090221598 Use of Sanglifehrin in HCV |
| 09/03/2009 | US20090221597 Heteroaryl derivatives as cftr modulators |
| 09/03/2009 | US20090221595 Crystalline form of sitagliptin |
| 09/03/2009 | US20090221594 Stable pharmaceutical compositions of 5, 10 methylenetrahydrofolate |
| 09/03/2009 | US20090221593 2-methyl-6-[(1R,5S/1S,5R)-3-(3-{[4-methyl-5-(4-methyl-1,3-oxazol-5-yl)-4H-1,2,4-triazol-3-yl]thio}propyl)-3-azabicyclo[3.1.0]hex-1-yl]quinoline, used to treat drug abuse and dependence, psychological disorders, urogenital disorders or as cognition activators |
| 09/03/2009 | US20090221592 New salt of sitagliptin; exhibits physicochemical properties, such as stability to stress, rendering it particularly suitable for the manufacture of various pharmaceutical dosage forms; Type 2 diabetes |
| 09/03/2009 | US20090221591 Selective Inhibitors of Human Corticosteroid Synthases |
| 09/03/2009 | US20090221590 Salt of cd 80 antagonist |
| 09/03/2009 | US20090221589 Use of aminoalcohol derivatives for the treatment of overactive bladder |
| 09/03/2009 | US20090221586 Oxazole compound and pharmaceutical composition |
| 09/03/2009 | US20090221585 Novel compounds and their use related to compositions for treating disease |
| 09/03/2009 | US20090221584 Bisaryl-sulfonamides |
| 09/03/2009 | US20090221583 such as 4-Benzenesulfinyl-N-{2-oxo-2-[4-(2-trifluoromethyl-benzoyl)-piperazin-1-yl]-ethyl}-benzamide, used for the treatment of syndrome X, obesity, insulin resistance, dyslipidemia and cardiovascular diseases |
| 09/03/2009 | US20090221582 Piperazine Derivatives And Their Use In Therapy |
| 09/03/2009 | US20090221581 Methods of treating pain |
| 09/03/2009 | US20090221580 Substituted aminopropenyl piperidine or morpholine derivatives as novel inhibitors of histone deacetylase |
| 09/03/2009 | US20090221579 Substituted Amino-Compounds and Uses Thereof |
| 09/03/2009 | US20090221578 Organic Compounds |
| 09/03/2009 | US20090221577 Compounds having morpholinyl and piperidinyl groups for use as glyt1 inhibitors |
| 09/03/2009 | US20090221576 Pharmaceutical Use of 2-Hydroxy-3-[5-(Morpholin-4-Ylmethyl) Pyridin-2-YL]-1H-IN-Dole-5-Carbonitrile as a Free Base or Salts |
| 09/03/2009 | US20090221575 Sulfonamide derivatives and use thereof for the modulation of metalloproteinases |
| 09/03/2009 | US20090221574 5-Lipoxygenase-Activating Protein (FLAP) Inhibitors |
| 09/03/2009 | US20090221573 Use of Activators of Soluble Guanylate Cyclase for Promoting Wound Healing |
| 09/03/2009 | US20090221572 4,5,6,7-tetrahydrobenzo[b]thiophene derivatives and their use as sigma receptor ligands |
| 09/03/2009 | US20090221571 Hiv integrase inhibitors |
| 09/03/2009 | US20090221570 Uses of 2-Phenyl-Substituted Imidazotriazinone Derivatives for Treating Pulmonary Hypertension |
| 09/03/2009 | US20090221569 Use of lhrh antagonists for intermittent treatments |
| 09/03/2009 | US20090221568 Synthesis of Inhibitors of FtsZ |
| 09/03/2009 | US20090221567 Muscarinic receptor agonists, compositions, methods of treatment thereof, and processes for preparation thereof 177 |
| 09/03/2009 | US20090221566 Inhibitors of phosphodiesterase type-iv |
| 09/03/2009 | US20090221565 8-Fluoro-3-methyl-6-oxo-9-[(R)-3-(thiazol-2-ylamino)-pyrrolidin-1-yl]-2,3-dihydro-6H-1-oxa-3,3a-diaza-phenalene-5-carboxylic acid; can be solid or liquid |
| 09/03/2009 | US20090221564 Heterocyclic Compounds and Their Use in the Treatment of Cardiovascular Disease |
| 09/03/2009 | US20090221563 meloxicam suspended in an aqueous glycerol mixture, cellulose thickening agent, taste modifying agents ( sweeteners) and a buffer system for maintaining pH in a range 2 to 4, free of SiO2; alleviating pain and inflammation in both acute and chronic musculo-skeletal disorders |
| 09/03/2009 | US20090221562 Novel opioid antagonists |
| 09/03/2009 | US20090221561 Cell Migration Modulating Compounds |
| 09/03/2009 | US20090221560 Pharmaceutical Formulation |
| 09/03/2009 | US20090221559 Benzodiazepines as hcv inhibitors |
| 09/03/2009 | US20090221558 Methods of modulating the activity of the mc5 receptor and treatment of conditions related to this receptor |
| 09/03/2009 | US20090221557 3-aminoalkyl-1,4-diazepan-2-one melanocortin-5 receptor antagonists |
| 09/03/2009 | US20090221556 Hydroxy and alkoxy substituted 1h-imidazoquinolines and methods |
| 09/03/2009 | US20090221555 FUSED BICYCLIC DERIVATIVES OF 2,4-DIAMINOPYRIMIDINE AS ALK AND c-MET INHIBITORS |
| 09/03/2009 | US20090221554 Method of treating cognitive impairment |
| 09/03/2009 | US20090221553 Methods for Treatment of Sexual Dysfunction |
| 09/03/2009 | US20090221552 Methods for the Treatment of ADHD and Related Disorders |
| 09/03/2009 | US20090221551 Substituted fused[1,2] imidazo[4,5c] ring compounds and methods |
| 09/03/2009 | US20090221550 Compositions for treatment of systemic mastocytosis |
| 09/03/2009 | US20090221549 Antihypertensive therapy |
| 09/03/2009 | US20090221548 Melanin concentrating hormone receptor-1 antagonists |
| 09/03/2009 | US20090221547 Immunosuppressant Compounds and Compositions |
| 09/03/2009 | US20090221546 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade |
| 09/03/2009 | US20090221545 Ophthalmic Pharmaceutical Composition Containing Amphiphilic Polyaspartamide Copolymers |
| 09/03/2009 | US20090221544 Methods for the treatment of a traumatic central nervous system injury via a tapered administration protocol |
| 09/03/2009 | US20090221543 New corticosteroids |
| 09/03/2009 | US20090221542 Inhibition of Inflammatory Cytokine Production With Tanshinones |
| 09/03/2009 | US20090221541 Pharmaceutical formulations |
| 09/03/2009 | US20090221540 Method of Treating An Acute Vascular Disorder |
| 09/03/2009 | US20090221539 Method of detecting and reducing boar taint using nuclear receptors |
| 09/03/2009 | US20090221538 Methods of treating multiple sclerosis by administering pulse dose calcitriol |
| 09/03/2009 | US20090221537 Use of 25-hydroxy vitamin d3 to improve vitality of animals |
| 09/03/2009 | US20090221536 Transdermal delivery of beneficial substances effected by a hostile biophysical environment |
| 09/03/2009 | US20090221535 2-(2,5-Dioxo-5,6-dihydro-4H-imidazo[1,5,4-de]quinoxalin-1(2H)-yl)-N-(3-methyl-spiro[imidazolidine-4,2'-indane]-2,5-dione)acetamide, used as Calcitonin Gene-Related Peptide (CGRP), ligands useful in the treatment or prevention of headaches |
| 09/03/2009 | US20090221534 Cox2 Inhibitor |